BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 1613697)

  • 1. c-myc mRNA expression in minor salivary glands of patients with Sjögren's syndrome.
    Skopouli FN; Kousvelari EE; Mertz P; Jaffe ES; Fox PC; Moutsopoulos HM
    J Rheumatol; 1992 May; 19(5):693-9. PubMed ID: 1613697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of CD40/CD40 ligand and Bcl-2 family proteins in labial salivary glands of patients with Sjögren's syndrome.
    Nakamura H; Kawakami A; Tominaga M; Migita K; Kawabe Y; Nakamura T; Eguchi K
    Lab Invest; 1999 Mar; 79(3):261-9. PubMed ID: 10092062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of BAFF (BLyS) in T cells infiltrating labial salivary glands from patients with Sjögren's syndrome.
    Lavie F; Miceli-Richard C; Quillard J; Roux S; Leclerc P; Mariette X
    J Pathol; 2004 Apr; 202(4):496-502. PubMed ID: 15095277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine mRNA expression in salivary gland biopsies of Sjögren's syndrome.
    Fox RI; Kang HI; Ando D; Abrams J; Pisa E
    J Immunol; 1994 Jun; 152(11):5532-9. PubMed ID: 8189070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant expression of BAFF by B lymphocytes infiltrating the salivary glands of patients with primary Sjögren's syndrome.
    Daridon C; Devauchelle V; Hutin P; Le Berre R; Martins-Carvalho C; Bendaoud B; Dueymes M; Saraux A; Youinou P; Pers JO
    Arthritis Rheum; 2007 Apr; 56(4):1134-44. PubMed ID: 17393395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Lymphoid" chemokine messenger RNA expression by epithelial cells in the chronic inflammatory lesion of the salivary glands of Sjögren's syndrome patients: possible participation in lymphoid structure formation.
    Xanthou G; Polihronis M; Tzioufas AG; Paikos S; Sideras P; Moutsopoulos HM
    Arthritis Rheum; 2001 Feb; 44(2):408-18. PubMed ID: 11229473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of interferon-inducible T cell alpha chemoattractant (CXCL11) in the salivary glands of patients with Sjögren's syndrome.
    Ogawa N; Kawanami T; Shimoyama K; Ping L; Sugai S
    Clin Immunol; 2004 Sep; 112(3):235-8. PubMed ID: 15308116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of cytokines in the destruction of acinar structure in Sjögren's syndrome salivary glands.
    Azuma M; Motegi K; Aota K; Hayashi Y; Sato M
    Lab Invest; 1997 Sep; 77(3):269-80. PubMed ID: 9314950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low salivary dehydroepiandrosterone and androgen-regulated cysteine-rich secretory protein 3 levels in Sjögren's syndrome.
    Laine M; Porola P; Udby L; Kjeldsen L; Cowland JB; Borregaard N; Hietanen J; Ståhle M; Pihakari A; Konttinen YT
    Arthritis Rheum; 2007 Aug; 56(8):2575-84. PubMed ID: 17665393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Abnormal interferon-inducible protein-10 expression in the labial glands of patients with Sjogren's syndrome].
    Zhou W; Dong Y; Zhao Y; Tang FL
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Oct; 25(5):603-7. PubMed ID: 14650168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different La/SS-B mRNA isoforms are expressed in salivary gland tissue of patients with primary Sjögren's syndrome.
    Bachmann M; Hilker M; Grölz D; Tellmann G; Hake U; Kater L; de Wilde P; Tröster H
    J Autoimmun; 1996 Dec; 9(6):757-66. PubMed ID: 9115578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of the interferon-gamma-induced T cell-attracting chemokines, interferon-gamma-inducible 10-kd protein (CXCL10) and monokine induced by interferon-gamma (CXCL9), in the salivary gland lesions of patients with Sjögren's syndrome.
    Ogawa N; Ping L; Zhenjun L; Takada Y; Sugai S
    Arthritis Rheum; 2002 Oct; 46(10):2730-41. PubMed ID: 12384933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salivary gland epithelial cells: a new source of the immunoregulatory hormone adiponectin.
    Katsiougiannis S; Kapsogeorgou EK; Manoussakis MN; Skopouli FN
    Arthritis Rheum; 2006 Jul; 54(7):2295-9. PubMed ID: 16802369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased circulating levels and salivary gland expression of interleukin-18 in patients with Sjögren's syndrome: relationship with autoantibody production and lymphoid organization of the periductal inflammatory infiltrate.
    Bombardieri M; Barone F; Pittoni V; Alessandri C; Conigliaro P; Blades MC; Priori R; McInnes IB; Valesini G; Pitzalis C
    Arthritis Res Ther; 2004; 6(5):R447-56. PubMed ID: 15380044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of interleukin-7 in labial salivary glands of patients with primary Sjögren's syndrome correlates with increased inflammation.
    Bikker A; van Woerkom JM; Kruize AA; Wenting-van Wijk M; de Jager W; Bijlsma JW; Lafeber FP; van Roon JA
    Arthritis Rheum; 2010 Apr; 62(4):969-77. PubMed ID: 20131250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of proteasomal immunosubunit beta1i is dysregulated in inflammatory infiltrates of minor salivary glands in Sjogren's syndrome.
    Morawietz L; Martinez-Gamboa L; Scheffler S; Hausdorf G; Dankof A; Kuckelkorn U; Doerner T; Egerer K; Burmester GR; Faustman DL; Feist E
    J Rheumatol; 2009 Dec; 36(12):2694-703. PubMed ID: 19833746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of phosphorylated STAT-1alpha in the labial salivary glands of patients with Sjögren's syndrome.
    Wakamatsu E; Matsumoto I; Yasukochi T; Naito Y; Goto D; Mamura M; Ito S; Tsutsumi A; Sumida T
    Arthritis Rheum; 2006 Nov; 54(11):3476-84. PubMed ID: 17075845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgens and integrins in salivary glands in Sjogren's syndrome.
    Porola P; Laine M; Virtanen I; Pöllänen R; Przybyla BD; Konttinen YT
    J Rheumatol; 2010 Jun; 37(6):1181-7. PubMed ID: 20436081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cell subpopulations in the labial minor salivary gland histopathologic lesion of Sjögren's syndrome.
    Skopouli FN; Fox PC; Galanopoulou V; Atkinson JC; Jaffe ES; Moutsopoulos HM
    J Rheumatol; 1991 Feb; 18(2):210-4. PubMed ID: 1827160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The CGGGG insertion/deletion polymorphism of the IRF5 promoter is a strong risk factor for primary Sjögren's syndrome.
    Miceli-Richard C; Gestermann N; Ittah M; Comets E; Loiseau P; Puechal X; Hachulla E; Gottenberg JE; Lebon P; Becquemont L; Mariette X
    Arthritis Rheum; 2009 Jul; 60(7):1991-7. PubMed ID: 19565491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.